Researchers say bat genome sequences may point to the identification and validation of molecular targets that could ultimately be harnessed to alleviate human aging and disease.
CZI and the IGI announce the funding of the Center for Pediatric CRISPR Cures to use CRISPR-based editing technology to advance cures.
Merck & Co. has agreed to acquire Verona Pharma for $10 billion, the companies said, in a deal designed to expand the pharma giant’s pipeline…
GREmLN leverages a graph-based architecture to represent gene-gene interactions to predict cell behavior for therapeutic applications.
Findings suggest that Alzheimer’s risk genes drive tau buildup and spread through both network-based and independent mechanisms.
Results reveal that weight loss has significant effects on cellular processes that are known to affect metabolic health and longevity.
In this GEN webinar, Gerben Zijlstra, PhD, and Jean-Marc Cappia, both experts in process intensification, explore the significance of PI in mAb production, emphasizing its…
Farmabios is equipped with specialized facilities for cytotoxic and sterile processing and supply chain and warehousing capabilities.
Revolution Medicine’s proprietary data will train a bespoke version of NeuralPLexer, an AI model for protein-ligand prediction from Iambic.
Researchers are working to launch a first-in-human clinical trial to test the approach in patients with cancer who develop diabetes after immunotherapy.
Fujifilm’s Life Sciences Group is renaming two of its companies, in a rebranding intended to position parent company Fujifilm as a strategic partner.
